Max-Planck-Institut für molekulare Biomedizin
About MPI für molekulare Biomedizin
The Max Planck Institute for Molecular Biomedicine is one of 80 research institutes of the Max Planck Society for the Advancement of Science (MPG). More than 150 researchers from around 25 nations work here, including biologists, physicians and physicists. As with all Max Planck Institutes, a large part of our budget comes from public funds, half from the federal government and half from the respective host state - in our case, the state of North Rhine-Westphalia. The focus of our work is basic research, i.e. the pursuit of new knowledge, without orientation towards industrial or commercial goals and in the service of the general public.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
